Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA panel recommends scaling back testosterone use in men, citing little evidence of benefit
FDA panel recommends scaling back testosterone use in men, citing little evidence of benefit
FDA panel recommends scaling back testosterone use in men, citing little evidence of benefit
Submitted by
admin
on September 18, 2014 - 8:57am
Source:
Yahoo/AP
News Tags:
FDA
advisory panels
testosterone
AbbVie
Eli Lilly
Headline:
FDA panel recommends scaling back testosterone use in men, citing little evidence of benefit
Do Not Allow Advertisers to Use My Personal information